Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Orthopaedic Surgery and Research|June 12, 2021
MiR-24-3p attenuates IL-1β-induced chondrocyte injury associated with osteoarthritis by targeting BCL2L12Jin Xu, Xiaozhong Qian, Ren Ding
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 22, 2015
Roflumilast combined with adenosine increases mucosal hydration in human airway epithelial cultures after cigarette smoke exposureJean Tyrrell, Xiaozhong Qian, Jose Freire, et al.
Molecular Oncology|April 23, 2009
Pharmacologically enhanced expression of GPNMB increases the sensitivity of melanoma cells to the CR011-vcMMAE antibody-drug conjugateXiaozhong Qian, Evan Mills, Michael Torgov, et al.
International Journal of Cancer|November 22, 2007
Activity of the histone deacetylase inhibitor belinostat (PXD101) in preclinical models of prostate cancerXiaozhong Qian, Gulshan Ara, Evan Mills, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibitionAndressa S Laino, David Woods, Melinda Vassallo, et al.
Molecular Cancer|September 16, 2008
Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cellsMarielle Dejligbjerg, Morten Grauslund, Thomas Litman, et al.
Respiratory Research|February 6, 2015
Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonistJavier Milara, Anselm Morell, Bea Ballester, et al.
Molecular Cancer Therapeutics|August 25, 2006
Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studiesXiaozhong Qian, William J LaRochelle, Gulshan Ara, et al.
Lipids in Health and Disease|December 6, 2021
Discordance between the triglyceride glucose index and HOMA-IR in incident albuminuria: a cohort study from ChinaWei Gao, Jialu Wang, Yan Chen, et al.
Journal of Translational Medicine|October 16, 2007
The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivoMichael T Buckley, Joanne Yoon, Herman Yee, et al.
Pageof 3